Fifth Affiliated Hospital, Sun Yat-sen University

Researchers are testing whether giving low-dose radiotherapy, the immunotherapy drug tislelizumab, and two chemotherapy drugs before surgery helps people with locally advanced head and neck squamous cell carcinoma. The trial enrolls adults with untreated, operable stage III to IV…

Researchers are testing whether adding the immunotherapy drug toripalimab to standard chemotherapy (gemcitabine and cisplatin) before surgery can help patients with locally advanced head and neck squamous cell carcinoma. The trial enrolls about 20 adults whose tumors can be remov…